At the same time, the corporation announced a new, $3 billion plant in the Netherlands to mass-produce a new pill form of the drug , a sign that the market is expected to grow significantly faster than existing factories can keep up
[11] [12] Other key factors include: Dose level : Higher doses (e.g., 12 mg in trial protocols) produced greater weight loss than lower doses, though they were also associated with a higher incidence of gastrointestinal side effects
When I wrote previously for this publication about the gap between GLP-1 prescribing rates and the clinical conversation around lean muscle preservation, the argument centred on a simple premise: weight loss is not fat loss, and the clinical infrastructure around these medications had not yet caught up with that distinction
A more established pathway may involve gallbladder and biliary effects
But a 4-8 week drug holiday is much shorter than the 28-52 week discontinuation periods in those studies